Export

ATC codes: P02BX04
EMLc
Indication
Fascioliasis ICD11 code: 1F82
INN
Triclabendazole
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Solid: 250 mg tablet
EML status history
First added in 1997 (TRS 882)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
Triclabendazole is the treatment of choice for Fasciola infections, a significant neglected tropical disease. Although not licensed for use in children in high-income countries, there is some experience of use of it. Noting that there are significant research gaps for medicines for children in this area, the EMLc Subcommittee decided to endorse this product as essential but highlighted the need for adequate studies to determine the effectiveness and safety of these medicines in children.